Skip to content
Aminoscope
Head-to-head

GlyNAC vs NAC (N-Acetylcysteine)

Not rival products: GlyNAC is NAC plus glycine, the second amino acid glutathione is built from. The real question is whether adding glycine buys you anything.

By Julian RothResearch & dataUpdated October 2026

Short answer

NAC has FDA approval and GlyNAC does not, which is the main thing separating them. NAC suits a reader who puts weight on FDA approval, while GlyNAC is marketed for glutathione, mitochondrial aging and healthspan. On the evidence, both have human clinical data.

GlyNAC

Glycine + NAC

Clinical data

Randomized trials report broad aging-marker improvement — but they're small, almost all from one group, and the lone independent trial missed its primary glutathione endpoint.

Full GlyNAC evidence review

NAC (N-Acetylcysteine)

Clinical data

A cysteine/glutathione precursor that is genuinely strong for specific medical uses (acetaminophen-overdose antidote, some psychiatry) but weak as an everyday 'antioxidant/detox' pill.

Full NAC (N-Acetylcysteine) evidence review

GlyNAC vs NAC (N-Acetylcysteine): head to head

FDA status / approved use

GlyNAC

Sold as a longevity supplement

NAC (N-Acetylcysteine)

Approved drug as an acetaminophen-overdose antidote and inhaled mucolytic; also widely sold as a supplement
Marketed for

GlyNAC

Glutathione, mitochondrial aging, healthspan

NAC (N-Acetylcysteine)

Antioxidant, detox
Outcome areas

GlyNAC

Mitochondrial / cellular energy; Longevity / lifespan; Liver / detox

NAC (N-Acetylcysteine)

Liver / detox; Mood / anxiety / stress
Evidence grade

GlyNAC

Clinical data

NAC (N-Acetylcysteine)

Clinical data
How it works

GlyNAC

Glycine plus NAC supply the building blocks to rebuild the antioxidant glutathione

NAC (N-Acetylcysteine)

Supplies cysteine, the limiting building block for the antioxidant glutathione
Route and dosing

GlyNAC

Not established

NAC (N-Acetylcysteine)

Oral supplement, commonly 600–1200 mg/day; intravenous in hospital for overdose
Headline human result

GlyNAC

A 114-person independent RCT missed its primary glutathione endpoint; positive trials are small and from one group

NAC (N-Acetylcysteine)

56% much or very much improved vs 16% on placebo at 12 weeks in a 50-patient trichotillomania RCT
Strongest evidence

GlyNAC

NAC (N-Acetylcysteine)

Key safety signal

GlyNAC

Reported safe and well tolerated in every human trial so far

NAC (N-Acetylcysteine)

Generally well tolerated; GI upset most common; IV use can cause anaphylactoid reactions
How it is obtained

GlyNAC

Over the counter as a dietary supplement

NAC (N-Acetylcysteine)

Over the counter as a dietary supplement

marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.

Clinical data:
Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).

Our verdict

These are a compositional pair, not competitors. GlyNAC's aging trials report a remarkably broad sweep of improved aging markers, including oxidative stress, mitochondrial function, gait speed and strength, but they are small, come almost entirely from one research group, and the single larger independent trial missed its primary glutathione endpoint. NAC alone has the longer clinical record, though nearly all of it is for specific medical uses rather than aging, and its daily antioxidant use is unsupported by outcome data. Both are cheap and well tolerated, both were reported safe in every trial, and neither has been shown to slow human aging.

GlyNAC fits if

Someone who wants the exact combination actually tested against aging markers and accepts that its most striking results remain unreplicated.

NAC (N-Acetylcysteine) fits if

Someone using cysteine repletion for one of NAC's better-documented purposes, or who simply wants the single cheaper ingredient without paying for the combination.

GlyNAC vs NAC (N-Acetylcysteine): common questions

Is NAC FDA-approved but GlyNAC not?
Yes. NAC is an approved drug as an acetaminophen-overdose antidote and inhaled mucolytic; also widely sold as a supplement. GlyNAC is sold as a longevity supplement.
Which has stronger human evidence, GlyNAC or NAC?
Neither clearly. Both have human clinical data. The key source for GlyNAC is RCT, J Gerontol A 2023; for NAC, it is Acetaminophen antidote, NEJM 2008.
What are the main safety concerns with GlyNAC and NAC?
GlyNAC is reported safe and well tolerated in every human trial so far. NAC is generally well tolerated; GI upset most common; IV use can cause anaphylactoid reactions.

Key studies behind each

GlyNAC

  1. Kumar P, Liu C, Suliburk J, et al. (2023). Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. PubMed 35975308
  2. Kumar P, Liu C, Hsu JW, et al. (2021). Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. Clin Transl Med. PubMed 33783984
  3. Kumar P, Osahon OW, Sekhar RV. (2022). GlyNAC Supplementation Improves Impaired Mitochondrial Fuel Oxidation and Lowers Insulin Resistance in Patients with Type 2 Diabetes: Results of a Pilot Study. Antioxidants (Basel). PubMed 35052658
  4. Lizzo G, Migliavacca E, Lametsch R, et al. (2022). A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage. Front Aging. PubMed 35821844

NAC (N-Acetylcysteine)

  1. Heard KJ. (2008). Acetylcysteine for acetaminophen poisoning. N Engl J Med. PubMed 18635433
  2. Deepmala, Slattery J, Kumar N, et al. (2015). Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. Neurosci Biobehav Rev. PubMed 25957927
  3. Grant JE, Odlaug BL, Kim SW. (2009). N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. PubMed 19581567
  4. Zheng JP, Wen FQ, Bai CX, et al. (2014). Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med. PubMed 24621680

The full evidence reviews

  • GlyNAC: impressive trials, an unsettled replication question

    Glycine + NAC restores glutathione and improved a broad sweep of aging markers in randomized human trials — but those trials are small, single-group, and the one independent attempt missed its primary endpoint.

    Updated August 2026

  • NAC (N-acetylcysteine): a real antidote, an oversold antioxidant

    NAC is the hospital-standard antidote for acetaminophen overdose and has real support in some psychiatry, as a mucolytic and for fertility — but the everyday 'antioxidant / detox / anti-aging' use it's mostly sold for is the weakest part of the story.

    Updated August 2026

Related comparisons